AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)

The summary for the AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Health Resources Services Administration, which is the U.S. government agency offering this grant.

AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF): This announcement solicits applications for the Ryan White HIV/AIDS Program Part B AIDS Drug Assistance Program (ADAP) Emergency Relief Funding (ERF), which enables the Secretary to utilize resources to control epidemics of any disease.  ADAP is administered by the Health Resources and Services Administration¿s (HRSA) HIV/AIDS Bureau (HAB), Division of State HIV/AIDS Programs. Limited New Competing ADAP ERF grant awards are intended for States/Territories that can demonstrate the need for additional resources to prevent, reduce or eliminate waitlists or implement ¿cost-cutting¿ and/or ¿cost-saving¿ measures.   Limited new competing ADAP ERF awards will be based on the applicant¿s ability to successfully demonstrate need for the additional funding and the success of the State¿s past efforts to improve the cost-effectiveness of ADAP operations consistent with HRSA recommendations and policies and to maximize available resources.  This determination will be made by an external Objective Review Committee (ORC) based on their review and scoring of applicant¿s responses to criteria published in this funding opportunity announcement (FOA), with priority given to addressing waiting lists. Important Note: States with an ADAP waiting list reported to HRSA must use all funding awarded under this announcement to remove clients from the waiting list. States that did not report a waiting list to HRSA, must use funding awarded under this announcement to address ¿cost-cutting¿ measures (e.g. reduction in ADAP eligibility below 300 percent of the Federal Poverty Level (FPL) and/or the formulary with respect to antiretroviral drugs and medications to treat opportunistic infections or HIV/AIDS complications) and/or support the implementation of ¿cost-saving¿ measures during the project period to prevent a waiting list.